Joint crisis plans for people with psychosis: Economic evaluation of a randomised controlled trial

British Medical Journal

Volumn 333, Issue 7571, 2006, Pages 729-732

  Flood, Chris ^a   Byford, Sarah ^b   Henderson, Claire ^b   Leese, Morven ^b   Thornicroft, Graham ^b   Sutherby, Kim ^d   Szmukler, George ^b,c  

^a CITY UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH CARE PLANNING; HEALTH SERVICE; HOSPITAL COST; HUMAN; PATIENT CARE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

COMMUNITY MENTAL HEALTH SERVICES; COST-BENEFIT ANALYSIS; ENGLAND; HUMANS; PATIENT CARE PLANNING; PSYCHOTIC DISORDERS; SINGLE-BLIND METHOD;

EID: 33749677548     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38929.653704.55     Document Type: Article

References (15)

1. Patel A, Knapp M. Costs of mental illness in England. Mental Health Res Rev 1998;5:4-10.
2. Morris S, Hogan T, McGuire A. The cost-effectiveness of clozapine. A survey of the literature. Clin Pharmacoeconomics 1998;15:137-52.
3. Rice D, Miller L. The economic burden of schizophrenia: conceptual and methodological issues, and cost estimates. In: Moscarelli M, Rupp A, Sartorius N, eds. Handbook of mental health economics and health policy. Vol 1. Schizophrenia. Chichester: John Wiley, 1996.
4. Henderson C, Flood C, Leese M, Thornicroft G, Sutherby K, Szmukler G. Effect of joint crisis plans on use of compulsory treatment in psychiatry: single blind randomised controlled trial. BMJ 2004;329:136-8.
5. Sutherby K, Szmukler GI, Halpern A, Alexander M, Thornicroft G, Johnson C, et al. A study of "crisis cards" in a community psychiatric service. Acta Psychiatr Scand 1999;100:56-61.
6. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, ed. Measuring mental health needs. London: Royal College of Physicians/Gaskell, 2001:200-24.
7. Knapp M, Chisholm D, McCrone P, Almond S, Amponsah S. The resource implications of the Mental Health Act. London: London School of Economics and Institute of Psychiatry, Kings College London, 1999.
8. Department of Health. NHS reference costs. London: DoH, 2001.
9. Netten A, Curtis L. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent, 2000.
10. Prison Service. Prison service annual report and accounts. London: Stationery Office, 2000.
11. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA, RPS, 2001. (No 42.)
12. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman and Hall, 1993.
13. Van Hout B, Al M, Gordon G. Costs, effects and c/e-ratios alongside a clinical trial. Health Econ 1994;3:309-19.
14. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87.
15. House of Lords House of Commons Joint Committee. Draft Mental Health Bill. Vol 1. London: Stationery Office, 2005. (HL Paper 79-1 HH.)